- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:38 | Envoy Medical, Inc.: Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement | 178 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - November 10, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully... ► Artikel lesen | |
| Do | Envoy Medical GAAP EPS of -$0.50, revenue of $66M | 2 | Seeking Alpha | ||
| ENVOY MEDICAL Aktie jetzt für 0€ handeln | |||||
| Do | Envoy Medical Q3 2026 Earnings Call Transcript | 7 | Benzinga.com | ||
| Do | Envoy Medical, Inc.: Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress | 134 | Newsfile | Company Reaches Six-Month Milestone in Pivotal Trial of Fully Implanted Cochlear ImplantSecond Module of Modular PMA Application Submitted to FDA Following Quarter EndWhite Bear Lake, Minnesota--(Newsfile... ► Artikel lesen | |
| Do | Envoy Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Do | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.10. | Envoy Medical, Inc.: Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th | 371 | Newsfile | Financial Results to Be Released Before Market OpenWhite Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health... ► Artikel lesen | |
| 27.10. | Envoy Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.10. | Envoy Medical, Inc.: Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th | 252 | Newsfile | Management Will Host a Conference Call at 4:30 P.M. ET on the Same DayWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company")... ► Artikel lesen | |
| 22.10. | Envoy Medical announces 1-for-10 reverse stock split | 6 | Investing.com | ||
| 22.10. | Envoy Medical, Inc.: Envoy Medical Announces Reverse Stock Split | 309 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully... ► Artikel lesen | |
| 20.10. | Envoy Medical, Inc.: Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design | 363 | Newsfile | Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit Final... ► Artikel lesen | |
| 16.10. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.10. | Envoy Medical stock price target maintained at $2 by H.C. Wainwright | 1 | Investing.com | ||
| 12.10. | Envoy Medical reicht zweites FDA-Modul für Acclaim-Implantat ein | - | Investing.com Deutsch | ||
| 12.10. | Envoy Medical submits second FDA module for Acclaim implant | 2 | Investing.com | ||
| 12.10. | Envoy Medical, Inc.: Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant | 568 | Newsfile | Second of Four Planned Modules Moves Rolling FDA Review ForwardAdvances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - October... ► Artikel lesen | |
| 07.10. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.10. | Lake Street stuft Envoy Medical mit "Buy" ein und sieht über 270 % Kurspotenzial | 1 | Investing.com Deutsch | ||
| 06.10. | Lake Street initiates Envoy Medical stock at buy on cochlear device | 2 | Investing.com |
1 2 3 4 Weiter >>
68 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 22,370 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| FRESENIUS | 53,69 | +2,34 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius Q3/2026 | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Fresenius Q3/2026 (News mit Zusatzmaterial)
04.11.2026 / 06:45 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,180 | +0,05 % | EQS-AFR: Siemens Healthineers AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Siemens Healthineers AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Siemens Healthineers AG: Vorabbekanntmachung... ► Artikel lesen | |
| HEARTFLOW | 56,65 | -0,02 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| PROGYNY | 35,960 | 0,00 % | Progyny, Inc. - 10-Q, Quarterly Report | ||
| FRESENIUS MEDICAL CARE | 41,260 | +0,71 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung gemäß § 50 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Drittstaatveröffentlichung nach § 50 Abs. 1, Nr. 2 WpHG
Fresenius Medical Care AG: Veröffentlichung gemäß §... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 4,005 | +0,12 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| PRIVIA HEALTH GROUP | 24,535 | 0,00 % | Privia Health Group, Inc. - 10-Q, Quarterly Report | ||
| GUARDIAN PHARMACY SERVICES | 46,970 | -0,06 % | Guardian Pharmacy forecasts $1.44B-$1.46B 2026 revenue and $136M-$138M adjusted EBITDA as it expands in Texas and Alabama | ||
| ALIGNMENT HEALTHCARE | 7,265 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| GMR SOLUTIONS | 11,270 | 0,00 % | GMR Solutions Q3 2026 Earnings Call Transcript | ||
| INTUITIVE SURGICAL | 407,25 | -0,83 % | ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue? | ||
| ARDENT HEALTH | 17,980 | 0,00 % | Ardent Health raises 2026 adjusted EBITDA outlook to $500M-$535M as Kansas divestiture targets +40 bps margin lift | ||
| CONCENTRA GROUP | 42,430 | +0,13 % | Mizuho raises Concentra stock price target to $47 on strong results | ||
| UNITEDHEALTH | 356,60 | +0,56 % | UnitedHealth Group adds former CHOP CEO to board |
Das Unternehmen ENVOY MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 7,110 Euro und damit +0,14 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVOY MEDICAL INC finden Sie auf Wallstreet Online.